Nathaniel D. Sisterson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deep Brain Stimulation | 9 | 2024 | 832 | 2.010 |
Why?
|
Intralaminar Thalamic Nuclei | 2 | 2024 | 15 | 0.870 |
Why?
|
Radiosurgery | 9 | 2019 | 1342 | 0.710 |
Why?
|
Seizures | 7 | 2024 | 2957 | 0.660 |
Why?
|
Movement Disorders | 1 | 2021 | 459 | 0.570 |
Why?
|
Epilepsy | 3 | 2021 | 3290 | 0.540 |
Why?
|
Epilepsy, Generalized | 3 | 2024 | 178 | 0.520 |
Why?
|
Electric Stimulation Therapy | 1 | 2020 | 628 | 0.460 |
Why?
|
Acromegaly | 3 | 2019 | 310 | 0.390 |
Why?
|
Pituitary ACTH Hypersecretion | 3 | 2018 | 179 | 0.370 |
Why?
|
Implantable Neurostimulators | 2 | 2020 | 75 | 0.330 |
Why?
|
Adenoma | 3 | 2019 | 2160 | 0.220 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2021 | 46 | 0.190 |
Why?
|
Epilepsies, Partial | 2 | 2024 | 431 | 0.170 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2019 | 49 | 0.160 |
Why?
|
Sella Turcica | 1 | 2018 | 118 | 0.150 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2021 | 389 | 0.150 |
Why?
|
Electrodes, Implanted | 1 | 2022 | 840 | 0.140 |
Why?
|
Glossopharyngeal Nerve Diseases | 1 | 2016 | 10 | 0.140 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2017 | 63 | 0.140 |
Why?
|
Craniotomy | 1 | 2021 | 741 | 0.140 |
Why?
|
Cushing Syndrome | 1 | 2018 | 241 | 0.140 |
Why?
|
Internationality | 2 | 2018 | 1001 | 0.130 |
Why?
|
Immunoglobulin E | 1 | 2022 | 1495 | 0.130 |
Why?
|
Neuroma, Acoustic | 1 | 2019 | 459 | 0.130 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 549 | 0.120 |
Why?
|
Thalamus | 1 | 2020 | 1044 | 0.110 |
Why?
|
International Cooperation | 1 | 2018 | 1422 | 0.100 |
Why?
|
Retrospective Studies | 12 | 2024 | 80582 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2024 | 64651 | 0.080 |
Why?
|
Neural Pathways | 1 | 2020 | 3057 | 0.080 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1324 | 0.080 |
Why?
|
Electroencephalography | 1 | 2024 | 6224 | 0.080 |
Why?
|
Humans | 22 | 2024 | 761423 | 0.070 |
Why?
|
Adolescent | 8 | 2024 | 88313 | 0.070 |
Why?
|
Young Adult | 9 | 2024 | 59207 | 0.060 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2024 | 54 | 0.060 |
Why?
|
Adult | 12 | 2024 | 221148 | 0.060 |
Why?
|
Freedom | 1 | 2021 | 69 | 0.050 |
Why?
|
Female | 14 | 2024 | 392581 | 0.050 |
Why?
|
Male | 12 | 2024 | 360736 | 0.040 |
Why?
|
Quality of Life | 1 | 2022 | 13361 | 0.040 |
Why?
|
Middle Aged | 11 | 2024 | 220826 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2024 | 1736 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15650 | 0.040 |
Why?
|
Probability | 1 | 2024 | 2478 | 0.040 |
Why?
|
Aged | 9 | 2019 | 169235 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9031 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39117 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 618 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 598 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58956 | 0.030 |
Why?
|
Cohort Studies | 4 | 2019 | 41446 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 2019 | 638 | 0.030 |
Why?
|
Brain | 1 | 2021 | 27107 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2021 | 1695 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2019 | 1931 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1051 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2018 | 1815 | 0.020 |
Why?
|
Reoperation | 1 | 2019 | 4303 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2824 | 0.020 |
Why?
|
Hippocampus | 1 | 2021 | 3763 | 0.020 |
Why?
|
Child | 3 | 2024 | 80162 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6479 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9612 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20093 | 0.020 |
Why?
|
Incidence | 1 | 2018 | 21341 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29620 | 0.010 |
Why?
|